Philippe Steg
Declaration of interest
| Function | Company |
|---|---|
| None |
Latest contributions
New insights into pharmacological treatment for STEMI
21 May 2026 – From EuroPCR 2026
This session presents the latest pharmacological advances in the treatment of ST-segment elevation myocardial infarction (STEMI). It covers safety data on ticagrelor monotherapy post-primary PCI, the impact of P2Y12 inhibitor pretreatment, effects of dapagliflozin on myocardial remodeling, and considerations for bleeding risk and vascular preparation strategies...
PCR Spotlight: COVID-19 - planned and ongoing trials
02 Jun 2020
Interventional Cardiologists P. G. Steg, Paris, France, and W. Wijns, Galway, Ireland, discuss the planned and ongoing trials related to COVID-19
